Allocations
Investment banking advisory firm Evercore has extended its strategic alliance for cross-border M&A advisory services with Korea’s NH Investment & Securities for an additional two year period.
The advisory alliance enables Evercore and NH to continue to capitalise on what they believe to be a positive long-term trend driving cross-border M&A activity in Asia.
Ralph Schlosstein, Evercore's president and chief executive officer, says: "We are pleased to extend and expand our Alliance with NH, which we established in 2011. Our longstanding relationship with NH is an important part of our global strategy and enables Evercore and NH to serve domestic
Livingstone’s consumer sector team has advised the management team of Long Tall Sally, a multi-channel retailer of fashion for taller women, on the GBP30 million acquisition of the business by Equistone-backed TriStyle Mode.
Founded in 1975, East London-based Long Tall Sally, led by CEO Andrew Shapin and backed by Amery Capital, offers taller women fashion through its 26 stores located in the UK, Canada, Germany and the US, and its online offering.
The business will continue to be operated independently by the existing management team led by Shapin and Amery Capital Chairman Maurice Helfgott post-acquisition, with both Shapin and
Boutique asset manager Unigestion has held the first close of its fourth dedicated private equity secondaries fund, Unigestion Secondaries Opportunities IV (USO IV).
The fund represents a continuation of the secondaries strategy that Unigestion has deployed since 2000.
USO IV has now received commitments in excess of EUR177 million, which is almost 60 per cent of the fund’s target size. Unigestion is seeking total commitments of EUR300 million.
USO IV seeks transactions at the smaller end of the secondary market, in which high-quality assets can be acquired at attractive valuations. It focuses on small and middle-market funds, fund
An affiliate of private equity and alternative asset investment firm HIG Capital has acquired CABLExpress Corporation d/b/a CXtec and TERACAI Corporation.
Headquartered in Syracuse, New York, CXtec is a provider of refurbished networking and telephony hardware and data centre cabling products to a diverse base of blue-chip customers.
Since its founding in 1978, CXtec and its equal2new brand of certified pre-owned equipment have established a market-leading position with deep domain expertise. CXtec’s systems and testing / certification processes ensure that IT procurement professionals are able to maintain and extend the life-cycle of existing IT infrastructure equipment by purchasing reliable
HIG Europe, the European arm of global private equity firm HIG Capital, is to sell the International School of Europe Group (ISE).
Closing of the transaction is expected in mid-September 2016. Terms have not been disclosed.


ISE, founded in 1958 by the Formiga family, is a group of schools in Italy with over 1,800 local and expatriate students between the ages of three and 18 years old in Milan, Modena, Monza and Siena. ISE is one of the leading IB schools in Europe.
Raffaele Legnani, managing director of HIG and head of HIG’s activities in Italy, says: “Paolo and
Noerr has advised Isaria Wohnbau on its capital increase carried out in connection with its takeover by the US private equity investor Lone Star.
The cash raised amounted to around EUR53 million.
At the same time, Noerr assisted the Munich-based project development company in cancelling the admission of its shares to trading on the regulated market of Frankfurt Stock Exchange.
This was the first withdrawal from the stock market under the new rules on delisting which have been in force since the end of 2015.
A team led by Noerr partners Dr Laurenz Wieneke and Dr Stephan
Early-stage venture capital firm True Ventures has raised USD310 million for its fifth fund, True Ventures V.
With the close of this fund, True now manages approximately USD1.3 billion in capital.
True received support from substantially all of its existing investor base and a few new institutional investors.
Celebrating its 10-year anniversary this year, True Ventures has enjoyed a consistent track record of success in multiple markets including connected hardware, enterprise software and infrastructure.
Successful investments include Fitbit (NYSE: FIT), MakerBot (acquired by Stratasys), Goodreads (acquired by Amazon), BrightRoll (acquired by Yahoo!), and Automattic (the company behind
Guardian Capital Partners has acquired Carson-Dellosa Publishing in partnership with the firm’s existing executive management team, which will continue operating the company going forward.
Headquartered in Greensboro, North Carolina, Carson-Dellosa is a provider of K-8 supplemental education content for parents, teachers and students with a portfolio of brands including Spectrum, Summer Bridge and Carson-Dellosa Education.
With 35 years of experience in the consumer educational products market, the company offers digital and print workbooks, test-prep, hands-on learning materials and classroom décor and resources.
Carson-Dellosa’s products are used in over 1,000 schools and can be purchased at over 10,000 retail
Funds managed by Alpina Partners have acquired Cimdata from Infoniqa Holding and iLab24.
Cimdata will now become part of a larger group of enterprise software businesses focusing on enterprise resource planning (ERP).
Alpina has previously acquired a majority stake in Oxaion, an ERP software company based in Ettlingen, Germany.
Terms of the transaction have not been disclosed.
“We are happy to welcome Cimdata as new member of our software buy-and-build platform. The company is a well-respected supplier of specialised ERP software solutions with a clear focus on the manufacturing industry,” says Florian Strehle, partner at Alpina Partners.
BioLineRx, a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing new drugs, has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing new therapies.
The joint venture, named iPharma, will develop clinical and pre-clinical therapeutic candidates originating primarily in Israel to serve the Chinese and global healthcare markets.
Under the terms of the JV agreement, each partner will provide seed capital of one million dollars to the venture. BioLineRx will screen and identify promising early-stage drug candidates originating primarily in Israel with emphasis on therapeutic indications that are of special
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
